Official blog
Compliance-aware guides and brand updates for adult consumers.
Page 19 of 35 / 832 articles
From baseball players with cheekfuls of dip to soccer stars vaping on the sidelines, nicotine use is endemic in professional sports. It's not just addiction—athletes use nicotine as a performance tool. The sports world has a nicotine problem it's barely begun to acknowledge.
On college campuses, nicotine use is increasingly framed as a performance enhancer—not a party drug, not a stress reliever, but a study tool. The normalization of 'nicotine for grades' represents a shift in how young adults relate to the molecule—and a challenge for prevention.
As tobacco farming declines, the genetic diversity of Nicotiana tabacum and its wild relatives is at risk—diversity that could be valuable for plant science, pharmaceutical production, and ecological research. The seed bank paradox: do we preserve the genetics of a crop that kills people?
A vaper in Australia—where nicotine vaping products require a prescription—can order flavored vape pods from a website in New Zealand and receive them in five days. National tobacco regulation is dying. The internet is the executioner.
The social contract around smoking is broken. Smokers are stigmatized, excluded, and blamed for their addiction. Nonsmokers are exposed to secondhand smoke, burdened with healthcare costs, and told to be compassionate. The contract needs renegotiation.
Relapse is not just a failure of willpower. It's a homecoming—a return to a familiar self, a familiar set of rituals, a familiar way of being in the world. Understanding the 'relapse as homecoming' dynamic is essential to preventing it.
A cigarette smoker loses an average of 10 years of life. A long-term NRT user loses approximately zero. The same drug. Different delivery systems. The lifespan gap is the most important number in nicotine policy—and the least discussed.
From the humble cigalike to the temperature-controlled DNA mod, vaping hardware evolved at an extraordinary pace. The devices that defined each era are artifacts of a technological explosion that has been largely forgotten—and that the regulatory system has brought to an end.
Philip Morris doesn't sell cigarettes anymore—it sells a 'smoke-free future.' BAT invests in wellness startups. The industry is repositioning itself as part of the solution. The rebranding is audacious, well-funded, and partly true. It's also a strategy for regulatory survival.
Nicotine withdrawal doesn't just affect your brain. It affects your gut—motility, microbiome, appetite, metabolism. The gastrointestinal dimension of quitting is one of the most underappreciated barriers to successful cessation.
Every stage of the cigarette lifecycle—farming, curing, manufacturing, distribution, consumption, disposal—generates carbon emissions, deforestation, water pollution, and toxic waste. The environmental cost of the cigarette is almost entirely externalized. It shouldn't be.
The most effective youth nicotine prevention programs don't involve adults telling kids what to do. They involve kids telling each other—through peer counseling, social norming, and the most powerful force in adolescent life: the desire to be like your friends.
Pipe smoking—slow, contemplative, and resolutely analog—is experiencing a quiet revival among a demographic that has never known a world without vaping. The revival is tiny, niche, and revealing of a deeper cultural need that the nicotine industry has forgotten how to serve.
Cigarette taxes are the single most effective policy for reducing smoking. They are also the most regressive—falling hardest on the poorest smokers. The tension between effectiveness and fairness is the central unresolved dilemma of tobacco taxation.
A growing subculture treats nicotine not as an addiction to be managed but as a cognitive tool to be optimized—microdosing, cycling, and 'stacking' nicotine with other nootropics. The optimization framework is seductive. It's also dangerous.
Smokers who quit are told to focus on what they're gaining: health, years of life, freedom from addiction. Almost nobody talks about what they're losing. The grief of quitting is real—and acknowledging it may be the key to surviving it.
A new generation of harm reduction communicators—YouTubers, TikTokers, podcasters—are reaching nicotine users with messages that public health institutions cannot deliver. The institutions are losing the audience. The influencers are winning it.
We now have a decade and a half of population-level data on vaping. The fears that animated the early debate—gateway effects, renormalization, youth epidemics—have not materialized as predicted. The benefits have materialized more strongly than expected. The evidence is in. Is anyone listening?
A new wave of nicotine startups is bypassing retail entirely, selling pouches and vapes through subscription models that collect user data, build brand loyalty, and operate in a regulatory gray zone. The future of nicotine retail doesn't happen at the counter. It arrives in your mailbox.
Nicotine is a stimulant that masks fatigue. For shift workers, new parents, and the chronically sleep-deprived, it's not just an addiction—it's a survival strategy. Understanding nicotine as sleep replacement reveals a dimension of addiction that the medical model cannot reach.
Writers, musicians, painters, and performers smoke at rates far higher than the general population. The cigarette has been romanticized as a tool of creativity for centuries. The romance is real. The body count is realer.
Elementary schools are now teaching anti-vaping curricula to ten-year-olds—children who, in most cases, have never heard of vaping. The prevention programs may be planting the seed they're supposed to uproot.
The global tobacco supply chain is built on women's labor—in the fields, in the curing barns, in the home-based piecework of bidi rolling. The workers are female. The profits are male. The recognition is nowhere.
The FDA issues hundreds of warning letters. States announce crackdowns. Customs seizes shipments. But the volume of unauthorized nicotine products on the market barely budges. The gap between enforcement theater and enforcement reality is vast—and it's by design.
Products
Select a product to view details, highlights, and technical specifications.
